K23 MH086690/MH/NIMH NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	1
2005	3
2007	7
2008	3
2009	5
2010	7
2011	6
2012	6
2013	5
2014	4
2015	1
2017	7
2018	9
2019	5
2020	4
2023	2
2024	0

1

Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence.

Dunlop BW, Cha J, Choi KS, Nemeroff CB, Craighead WE, Mayberg HS. Dunlop BW, et al. Neuropsychopharmacology. 2023 Dec;48(13):1901-1909. doi: 10.1038/s41386-023-01653-w. Epub 2023 Jul 25. Neuropsychopharmacology. 2023. PMID: 37491672 Clinical Trial.

2

Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.

Dunlop BW, Cha J, Choi KS, Rajendra JK, Nemeroff CB, Craighead WE, Mayberg HS. Dunlop BW, et al. Am J Psychiatry. 2023 Mar 1;180(3):218-229. doi: 10.1176/appi.ajp.21070727. Epub 2023 Jan 18. Am J Psychiatry. 2023. PMID: 36651624 Clinical Trial.

3

Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depression.

Hershenberg R, McDonald WM, Crowell A, Riva-Posse P, Craighead WE, Mayberg HS, Dunlop BW. Hershenberg R, et al. J Affect Disord. 2020 Apr 1;266:22-29. doi: 10.1016/j.jad.2020.01.108. Epub 2020 Jan 22. J Affect Disord. 2020. PMID: 32056880 Free PMC article.

4

Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.

Ahmed AT, MahmoudianDehkordi S, Bhattacharyya S, Arnold M, Liu D, Neavin D, Moseley MA, Thompson JW, Williams LSJ, Louie G, Skime MK, Wang L, Riva-Posse P, McDonald WM, Bobo WV, Craighead WE, Krishnan R, Weinshilboum RM, Dunlop BW, Millington DS, Rush AJ, Frye MA, Kaddurah-Daouk R; Mood Disorders Precision Medicine Consortium (MDPMC). Ahmed AT, et al. J Affect Disord. 2020 Mar 1;264:90-97. doi: 10.1016/j.jad.2019.11.122. Epub 2019 Nov 30. J Affect Disord. 2020. PMID: 32056779 Free PMC article.

5

Investigation of MORC1 DNA methylation as biomarker of early life stress and depressive symptoms.

Thomas M, Coope A, Falkenberg C, Dunlop BW, Czamara D, Provencal N, Craighead WE, Mayberg HS, Nemeroff CB, Binder EB, Nieratschker V. Thomas M, et al. J Psychiatr Res. 2020 Jan;120:154-162. doi: 10.1016/j.jpsychires.2019.10.019. Epub 2019 Oct 26. J Psychiatr Res. 2020. PMID: 31683097 Free PMC article.

6

Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Jovanovic T, Duncan EJ, Kaye J, Garza K, Norrholm SD, Inslicht SS, Neylan TC, Mathew SJ, Iosifescu D, Rothbaum BO, Mayberg HS, Dunlop BW. Jovanovic T, et al. Psychophysiology. 2020 Jan;57(1):e13356. doi: 10.1111/psyp.13356. Epub 2019 Feb 26. Psychophysiology. 2020. PMID: 30807663 Free PMC article. Clinical Trial.

7

Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

Dunlop BW, LoParo D, Kinkead B, Mletzko-Crowe T, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE. Dunlop BW, et al. Am J Psychiatry. 2019 Apr 1;176(4):275-286. doi: 10.1176/appi.ajp.2018.18091075. Epub 2019 Feb 15. Am J Psychiatry. 2019. PMID: 30764648 Free PMC article. Clinical Trial.

8

DNA methylation levels are associated with CRF₁ receptor antagonist treatment outcome in women with post-traumatic stress disorder.

Pape JC, Carrillo-Roa T, Rothbaum BO, Nemeroff CB, Czamara D, Zannas AS, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Dunlop BW, Binder EB. Pape JC, et al. Clin Epigenetics. 2018 Nov 3;10(1):136. doi: 10.1186/s13148-018-0569-x. Clin Epigenetics. 2018. PMID: 30390684 Free PMC article. Clinical Trial.

9

Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse.

Kelley ME, Dunlop BW, Nemeroff CB, Lori A, Carrillo-Roa T, Binder EB, Kutner MH, Rivera VA, Craighead WE, Mayberg HS. Kelley ME, et al. Depress Anxiety. 2018 Oct;35(10):992-1000. doi: 10.1002/da.22832. Epub 2018 Sep 7. Depress Anxiety. 2018. PMID: 30260539 Free PMC article.

10

Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder.

Dunlop BW, Polychroniou PE, Rakofsky JJ, Nemeroff CB, Craighead WE, Mayberg HS. Dunlop BW, et al. Psychol Med. 2019 Aug;49(11):1869-1878. doi: 10.1017/S0033291718002568. Epub 2018 Sep 12. Psychol Med. 2019. PMID: 30207254 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year